Ontology highlight
ABSTRACT:
SUBMITTER: Mu W
PROVIDER: S-EPMC7567795 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
Nature communications 20201016 1
Two major treatment strategies employed in non-small cell lung cancer, NSCLC, are tyrosine kinase inhibitors, TKIs, and immune checkpoint inhibitors, ICIs. The choice of strategy is based on heterogeneous biomarkers that can dynamically change during therapy. Thus, there is a compelling need to identify comprehensive biomarkers that can be used longitudinally to help guide therapy choice. Herein, we report a <sup>18</sup>F-FDG-PET/CT-based deep learning model, which demonstrates high accuracy in ...[more]